期刊文献+

Sagliker综合征透析龄和骨代谢血液指标的初步研究 被引量:4

A preliminary study of dialysis age and bone metabolic blood index of Sagliker syndrome
下载PDF
导出
摘要 目的:初步探讨Sagliker综合征(SS)的病因,为进一步深入研究找到方向。方法:选择在中日友好医院肾内科和口腔医学中心确诊的SS患者(SS组)8例,单纯继发性甲状旁腺功能亢进患者(SHPT组)26例,比较2组患者在性别、年龄、发病原因及骨代谢相关血液指标等方面的差异。结果:透析龄均值SS组为146±45个月,单纯SHPT组为125±24个月;SS组碱性磷酸酶(ALP)浓度为1184±662U/L、血清全段甲状旁腺激素(iPTH)浓度为2109±391pg/ml,单纯SHPT组ALP浓度为491±170U/L、iPTH浓度为2371±345pg/ml。SS组iPTH浓度每增加100pg/ml,ALP浓度增加118.8U/L;单纯SHPT组iPTH浓度每增加100pg/ml,ALP浓度增加24.6U/L。结论:透析龄可能也是Sagliker综合征的一个危险因素。单纯SHPT患者iPTH浓度升高时,ALP浓度上升幅度随iPTH浓度上升幅度较以前明显增加时,其发展成为Sagliker综合征的可能性加大。 Objective:To explore the etiology of Sagliker syndrome and find the direction of further study. Methods:Select 8 patients of Sagliker syndrome(SS group)and 26 patients simple secondary hyperparathyroidism(simple SHPT group)who were diagnosed by the Department of Nephrology and Dental Medical Center of China-Japan Friendship Hospital.Differences between the two groups on gender,age,the cause of SHPT,and several bone metabolic related blood parameters were compared.Results:For SS group,the average of dialysis age was 146±45 months and for simple SHPT group it was 125±24 months;for SS group,the alkaline phosphatase(ALP)concentration was 1184±662U/L,serum intact parathyroid hormone(iPTH)concentration was 2109± 391pg/ml,and they were 491±170U/L and 2371±345pg/ml for simple SHPT group.When the iPTH concentration had a increasing of 100pg/ml,for SS group,ALP concentration had an increasing of 118.8U/L,but for simple SHPT group,ALP concentration only had a increasing of 24.6U/L.Conclusion:Dialysis age might be a risk factor of Sagliker syndrome.For simple SHPT patients,when ALP had a significant increasing with the increasing of iPTH,the possibility that they became Sagliker syndrome increased.
出处 《中日友好医院学报》 2013年第1期12-15,24,F0002,共6页 Journal of China-Japan Friendship Hospital
关键词 Sagliker综合征 继发性甲状旁腺功能亢进 病因 Sagliker syndrome secondary hyperparathyroidism etiology
  • 相关文献

参考文献10

  • 1Cohen J,Diamond I. Leontiasis ossea,slipped epiphyses,and granulosa cell tumor of testis with renal disease:report of a case with autopsy findings[J].AMA Arch Patho1,1953,(05):488-500.
  • 2Dantas M,Costa RS,Jorgetti V. Facial leontiasis ossea:a rare presentation of hyperparathyroidism secondary to chronic renal insufficiency[J].Nephron,1991,(04):475-478.
  • 3Lee VS,Martinez S. Leontiasis ossea in secondary hyperparathyroidism[J].Journal of Bone and Mineral Research,1997,(11):1952-1953.
  • 4Reidy JM,Motamedi K,Berens D. Renal osteodystrophy with leontiasis ossea deformity[J].Otolaryngology-Head & Neck Surgery,1998,(05):525-527.
  • 5Lee VS,Webb MS,Martinez S. Uremic leontiasis ossea:"bighead"disease in humans? Radiologic,clinical,and pathologic features[J].Radiology,1996.233-240.
  • 6Fisher D,Hiller N,Drukker A. Nephroquiz for the beginner:A swollen face in a girl on haemodialysis.Diagnosis:renal osteodystrophy[J].Nephrology Dialysis Transplantation,1999,(07):1797-1798.
  • 7Sagliker Y,Balal M,Sagliker Ozkaynak P. Sagliker syndrome:uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure[J].Semin Neohrol,2004,(05):449-455.
  • 8张凌,姚力,花瞻,卞维静,李文歌.甲状旁腺全切除术治疗10例Sagliker综合征疗效评估[J].中华内科杂志,2011,50(7):562-567. 被引量:27
  • 9Hoenderop JG,Nilius B,Bindels RJ. Molecular mechanism of active Ca2+ reabsorption in the distal nephron[J].Annual Review of Physiology,2002.529-549.
  • 10张建荣;张凌.慢性肾脏病继发性甲旁亢[M]北京:人民军医出版社,201023-24.

二级参考文献17

  • 1张凌.慢性肾脏病甲状旁腺功能亢进症的病理生理及临床表现//张建荣,张凌.慢性肾脏病继发性甲旁亢[脚.北京:人民军医出版社,2010:82-114.
  • 2Moranne 0, Froissart M, Rossert J, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol, 2009, 20 : 164-171.
  • 3Goodman WG, Goldin J, Kuizon BD, et al. Coronary-arte~ calcification in young adults with end-stage renal disease who are undergoing dialysis. N Eng J Med,2000,342:1478-1483.
  • 4Teresa A, Joao MF. Cardiovascular risk in dialysis patients : X-ray vision on vascular calfications. Kidney Int, 2008,74:1505-1507.
  • 5Kidney Disease: Improving Global Outcomes (KDIGO) CKD- MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Snpp1,2009 ,'( 113 ) : S1-130.
  • 6Raggi P, Kleerekoper M. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Clin J Am Soc Nephrol, 2008,3:836-843.
  • 7Cohen J, Diamond I. Leontiasis ossea, slipped epiphyses, and granulose cell tumor of testis with renal disease. Arch Pathol,1953, 56:488-500.
  • 8Dantas M, Costa RS, Jorgetti V, et al. Facial leontiasis ossea: a rare presentation of hyperparathyroidism secondary to chronic renal insufficiency. Nephron, 1991,58:475-478.
  • 9Lee VS, Martinez S. Leontiasis in secondary hyperparathyroidism. J Bone Miner Res, 1997,12 : 1952-1953.
  • 10Reidy JM, Motamedi K, Berens D, et al. Renal osteodystrophy with leontiasis ossea deformity. Otolaryngol Head Neck Surg, 1998,119:525-527.

共引文献26

同被引文献53

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部